Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR19042 in autoimmune hepatitis
NCT05476900Phase 2Completed
- Sponsor
- Hengrui
- Start
- Oct 2022
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HR19042 in autoimmune hepatitis (AIH), sponsored by Hengrui. Started Oct 2022; status: completed.
02
Drugs
HR19042
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT05476900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05476900.